Cancer
> Genetic mutations in 12 different kinds of cancer seem to drive the development and progression of tumors, according to new research from Washington University in St. Louis. More
> Preclinical study results of Oxigene's ($OXGN) Zybrestat showed reduced tumor growth and decreased insulin levels in a mouse model of pancreatic neuroendocrine tumors. Release
Kidney Disease
> German Evotec has partnered with AstraZeneca ($AZN) to find compounds and targets with novel mechanisms to treat kidney disease. Release
Neurological Disorders
> Researchers at Lincoln University in the U.K. have manufactured a new therapeutic molecule that could treat neurological disorders like chronic pain and epilepsy. Release